2M3Z

NMR solution structure of HIV-1 nucleocapsid protein in complex with an inhibitor displaying a 2 inhibitors:1 NC stoichiometry

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D HNCA	250 uM [U-100% 13C; U-100% 15N] protein, 500 uM inhibitor	90% H2O/10% D2O	0.025	6.5	ambient	300
2	3D HNCACB	250 uM [U-100% 13C; U-100% 15N] protein, 500 uM inhibitor	90% H2O/10% D2O	0.025	6.5	ambient	300
3	2D DQF-COSY	250 uM [U-100% 13C; U-100% 15N] protein, 500 uM inhibitor	90% H2O/10% D2O	0.025	6.5	ambient	300
4	2D 1H-1H NOESY	250 uM [U-100% 13C; U-100% 15N] protein, 500 uM inhibitor	90% H2O/10% D2O	0.025	6.5	ambient	300
5	2D 1H-15N HSQC	250 uM [U-100% 13C; U-100% 15N] protein, 500 uM inhibitor	90% H2O/10% D2O	0.025	6.5	ambient	300
6	3D CBCA(CO)NH	250 uM [U-100% 13C; U-100% 15N] protein, 500 uM inhibitor	90% H2O/10% D2O	0.025	6.5	ambient	300
7	3D HCCH-TOCSY	250 uM [U-100% 13C; U-100% 15N] protein, 500 uM inhibitor	90% H2O/10% D2O	0.025	6.5	ambient	300
8	3D 1H-15N NOESY	250 uM [U-100% 13C; U-100% 15N] protein, 500 uM inhibitor	90% H2O/10% D2O	0.025	6.5	ambient	300
9	3D 1H-13C NOESY aliphatic	250 uM [U-100% 13C; U-100% 15N] protein, 500 uM inhibitor	90% H2O/10% D2O	0.025	6.5	ambient	300

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600

NMR Refinement
Method	Details	Software
simulated annealing		Amber

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	100
Conformers Submitted Total Number	10
Representative Model	1 (fewest violations)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	Amber	8.0	Case, Darden, Cheatham, III, Simmerling, Wang, Duke, Luo, ... and Kollman
2	refinement	Amber		Case, Darden, Cheatham, III, Simmerling, Wang, Duke, Luo, ... and Kollman

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.